198 related articles for article (PubMed ID: 20174973)
1. Primary care physicians' attitudes regarding race-based therapies.
Frank D; Gallagher TH; Sellers SL; Cooper LA; Price EG; Odunlami AO; Bonham VL
J Gen Intern Med; 2010 May; 25(5):384-9. PubMed ID: 20174973
[TBL] [Abstract][Full Text] [Related]
2. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
Temple R; Stockbridge NL
Ann Intern Med; 2007 Jan; 146(1):57-62. PubMed ID: 17200223
[TBL] [Abstract][Full Text] [Related]
3. Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
Harv Heart Lett; 2005 Nov; 16(3):1-2. PubMed ID: 16363036
[No Abstract] [Full Text] [Related]
4. Influence of patient race on physician prescribing decisions: a randomized on-line experiment.
Rathore SS; Ketcham JD; Alexander GC; Epstein AJ
J Gen Intern Med; 2009 Nov; 24(11):1183-91. PubMed ID: 19705205
[TBL] [Abstract][Full Text] [Related]
5. Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
Ellison GT; Kaufman JS; Head RF; Martin PA; Kahn JD
J Law Med Ethics; 2008; 36(3):449-57. PubMed ID: 18840235
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
7. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
Bibbins-Domingo K; Fernandez A
Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222
[TBL] [Abstract][Full Text] [Related]
8. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Carmody MS; Anderson JR
Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
[TBL] [Abstract][Full Text] [Related]
9. BiDil: assessing a race-based pharmaceutical.
Brody H; Hunt LM
Ann Fam Med; 2006; 4(6):556-60. PubMed ID: 17148635
[TBL] [Abstract][Full Text] [Related]
10. "Special treatment": BiDil, Tuskegee, and the logic of race.
Reverby SM
J Law Med Ethics; 2008; 36(3):478-84. PubMed ID: 18840239
[TBL] [Abstract][Full Text] [Related]
11. The paradox of race in the Bidil debate.
Crawley L
J Natl Med Assoc; 2007 Jul; 99(7):821-2. PubMed ID: 17668653
[No Abstract] [Full Text] [Related]
12. Bidil: recontextualizing the race debate.
Séguin B; Hardy B; Singer PA; Daar AS
Pharmacogenomics J; 2008 Jun; 8(3):169-73. PubMed ID: 18195727
[No Abstract] [Full Text] [Related]
13. Prescribing BiDil: is it black and white?
Haga SB; Ginsburg GS
J Am Coll Cardiol; 2006 Jul; 48(1):12-4. PubMed ID: 16814642
[TBL] [Abstract][Full Text] [Related]
14. Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
Dorr GM; Jones DS
J Law Med Ethics; 2008; 36(3):443-8. PubMed ID: 18840234
[No Abstract] [Full Text] [Related]
15. Physicians' attitudes toward race, genetics, and clinical medicine.
Bonham VL; Sellers SL; Gallagher TH; Frank D; Odunlami AO; Price EG; Cooper LA
Genet Med; 2009 Apr; 11(4):279-86. PubMed ID: 19265721
[TBL] [Abstract][Full Text] [Related]
16. The effect of cognitive load and patient race on physicians' decisions to prescribe opioids for chronic low back pain: a randomized trial.
Burgess DJ; Phelan S; Workman M; Hagel E; Nelson DB; Fu SS; Widome R; van Ryn M
Pain Med; 2014 Jun; 15(6):965-74. PubMed ID: 24506332
[TBL] [Abstract][Full Text] [Related]
17. FDA approves heart drug for black patients.
Meadows M
FDA Consum; 2005; 39(5):8-9. PubMed ID: 16419285
[TBL] [Abstract][Full Text] [Related]
18. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
19. BiDil: primary care physicians first and cardiologist when?
Matthews GE
J Natl Med Assoc; 2007 Jun; 99(6):697-9; quiz 700. PubMed ID: 17595944
[No Abstract] [Full Text] [Related]
20. BiDil for heart failure in black patients.
Kahn JD
Ann Intern Med; 2007 Aug; 147(3):215; author reply 215-6. PubMed ID: 17679713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
